Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.
Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. Among authors: levitt ml. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements.
Neuenschwander FC, Barnett-Griness O, Piconi S, Maor Y, Sprinz E, Assy N, Khmelnitskiy O, Lomakin NV, Goloshchekin BM, Nahorecka E, Joaquim Westheimer Calvacante A, Ivanova A, Vladimirovich Zhuravel S, Yurevna Trufanova G, Bonora S, Saffoury A, Mayo A, Shvarts YG, Rizzardini G, Sobroza de Mello R, Pilau J, Klinov A, Valente-Acosta B, Olegovich Burlaka O, Bakhtina N, Bar-Meir M, Nikolaevich Shishimorov I, Oñate-Gutierrez J, García Rincón CI, Ivanovna Martynenko T, Hajjar LA, Carolina Nazare de Mendonca Procopio A, Simon K, Gabriel Chaves Santiago W, Fronczak A, Roberto Hoffmann Filho C, Hussein O, Aleksandrovich Martynov V, Chichino G, Blewaska P, Wroblewski J, Saul Irizar Santana S, Felipe Ocampo Agudelo A, Barczyk A, Lask Gerlach R, Campbell E, Bibliowicz A, Fathi R, Anderson P, Raday G, Klein M, Fehrmann C, Eagle G, Ben-Yair VK, Levitt ML. Neuenschwander FC, et al. Among authors: levitt ml. Microorganisms. 2024 Aug 26;12(9):1767. doi: 10.3390/microorganisms12091767. Microorganisms. 2024. PMID: 39338442 Free PMC article.
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
Asumda FZ, Campbell NA, Hassan MA, Fathi R, Vasquez Rico DF, Kiem M, Vang EV, Kim YH, Luo X, O'Brien DR, Buhrow SA, Reid JM, Moore MJ, Ben-Yair VK, Levitt ML, Leiting JL, Abdelrahman AM, Zhu X, Lucien F, Truty MJ, Roberts LR. Asumda FZ, et al. Among authors: levitt ml. Cancers (Basel). 2024 Mar 5;16(5):1050. doi: 10.3390/cancers16051050. Cancers (Basel). 2024. PMID: 38473407 Free PMC article.
Recent Progress in the Development of Opaganib for the Treatment of Covid-19.
Smith CD, Maines LW, Keller SN, Katz Ben-Yair V, Fathi R, Plasse TF, Levitt ML. Smith CD, et al. Among authors: levitt ml. Drug Des Devel Ther. 2022 Jul 12;16:2199-2211. doi: 10.2147/DDDT.S367612. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35855741 Free PMC article. Review.
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
Winthrop KL, Skolnick AW, Rafiq AM, Beegle SH, Suszanski J, Koehne G, Barnett-Griness O, Bibliowicz A, Fathi R, Anderson P, Raday G, Eagle G, Ben-Yair VK, Minkowitz HS, Levitt ML, Gordon MS. Winthrop KL, et al. Among authors: levitt ml. Open Forum Infect Dis. 2022 May 11;9(7):ofac232. doi: 10.1093/ofid/ofac232. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35832268 Free PMC article.
Gefitinib in recurrent glioblastoma.
Pfeffer MR, Levitt ML, Aderka D. Pfeffer MR, et al. Among authors: levitt ml. J Clin Oncol. 2004 Jul 1;22(13):2755-6; author reply 2756. doi: 10.1200/JCO.2004.99.299. J Clin Oncol. 2004. PMID: 15226353 No abstract available.
Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms.
Levitt ML, Kassem B, Gooding WE, Miketic LM, Landreneau RJ, Ferson PF, Keenan R, Yousem SA, Lindberg CA, Trenn MR, Ponas RS, Tarasoff P, Sabatine JM, Friberg D, Whiteside TL. Levitt ML, et al. Lung Cancer. 2004 Mar;43(3):335-44. doi: 10.1016/j.lungcan.2003.09.011. Lung Cancer. 2004. PMID: 15165093 Clinical Trial.
35 results